Interferon alfa (pegylated and non-pegylated) and ribavirin for the treatment of chronic hepatitis C

View the summary and implementation tools

This is an extract from the guidance and may be misleading if read alone. The complete guidance is available at guidance.nice.org.uk/ta75

Important information about this guidance

This guidance replaces 'Hepatitis C - alpha interferon and ribavirin' (NICE Technology Appraisal Guidance No. 14 issued in October 2000). This guidance is extended by 'Hepatitis C – peginterferon alfa and ribavirin (TA106, www.nice.org.uk/ta106)

This guidance has been partially updated by 'Peginterferon alfa and ribavirin for the treatment of chronic hepatitis C' (NICE technology appraisal guidance 200). See the guidance and quick reference guide at www.nice.org.uk/ta200 for more details.